Table 2.
Medical management, based on the results of the local survey [14]
| Medical management | SNRIa (%) | SSRI (%) |
|---|---|---|
| Reasons for change | ||
| Lack of efficacy | 59.43 | 73.32 |
| Lack of tolerability | 40.57 | 26.68 |
| Therapeutic changes | ||
| Lack of tolerability | ||
| Switch to SNRI | 21.94 | 53.28 |
| Switch to SSRI | 63.25 | 32.99 |
| Switch to psychotherapy | 14.81 | 13.73 |
| Lack of efficacy | ||
| Switch to SNRI | 5.41 | 19.50 |
| Switch to SSRI | 12.87 | 4.54 |
| Titration | 45.58 | 41.40 |
| Combination with bupropion | 11.19 | 9.33 |
| Combination with psychotherapy | 16.23 | 19.70 |
| Augmentation with quetiapine | 5.84 | 3.44 |
| Switch to psychotherapy | 2.89 | 2.09 |
NA not applicable, SNRI serotonin–norepinephrine reuptake inhibitor, SSRI selective serotonin reuptake inhibitor
aSNRI: including mirtazapine